NCT06290934 Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06263543 Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC Status RECRUITING Phase PHASE2
NCT06250036 Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer Status SUSPENDED Phase PHASE2
NCT06248515 A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors Status RECRUITING Phase PHASE2
NCT06238921 Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT06177574 Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW) Status COMPLETED Phase PHASE4
NCT06167317 Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06165614 Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya Status COMPLETED Phase PHASE1
NCT06148610 Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support Status RECRUITING Phase N/A
NCT06123468 Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT06104306 Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER) Status COMPLETED Phase PHASE4
NCT06101342 Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06101329 Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06100874 A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06082960 Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06081244 NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) Status RECRUITING Phase PHASE3
NCT06071767 Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 Status RECRUITING Phase PHASE1/PHASE2
NCT06065371 Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy Status RECRUITING Phase PHASE1